Literature DB >> 11980980

Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance.

Matthias Schröter1, Bernhard Zöllner, Peter Schäfer, Andreas Reimer, Matthias Müller, Rainer Laufs, Heinz-Hubert Feucht.   

Abstract

This study demonstrates the dynamics in the epidemiology of hepatitis C virus subtypes. Subtypes 3a and 4a have become increasingly prevalent in patients where an infection within recent years can be assumed. Evidence is presented that the subtypes observed among younger patients can spread rapidly and lead to significant changes in the subtype distribution.

Entities:  

Mesh：

Year:  2002        PMID： 11980980      PMCID： PMC130918          DOI： 10.1128/JCM.40.5.1866-1868.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  Peginterferon alfa-2a in patients with chronic hepatitis C.

Authors:  S Zeuzem; S V Feinman; J Rasenack; E J Heathcote; M Y Lai; E Gane; J O'Grady; J Reichen; M Diago; A Lin; J Hoffman; M J Brunda
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

2.  Changes in the epidemiology of hepatitis C infection in Germany: shift in the predominance of hepatitis C subtypes.

Authors:  R S Ross; S Viazov; K Renzing-Köhler; M Roggendorf
Journal:  J Med Virol       Date:  2000-02       Impact factor: 2.327

3.  The influence of age on the prevalence of hepatitis C virus subtypes 1a and 1b.

Authors:  H H Feucht; M Schröter; B Zöllner; S Polywka; H Nolte; R Laufs
Journal:  J Infect Dis       Date:  1997-03       Impact factor: 5.226

4.  Hepatitis C virus infection in spouses: sexual transmission or common exposure to the same risk factors?

Authors:  T Stroffolini; U Lorenzoni; F Menniti-Ippolito; D Infantolino; M Chiaramonte
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

5.  Chronic hepatitis C in Sweden: genotype distribution over time in different epidemiological settings.

Authors:  J Westin; M Lindh; L M Lagging; G Norkrans; R Wejstål
Journal:  Scand J Infect Dis       Date:  1999

6.  Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative Study Group.

Authors:  N N Zein; J Rakela; E L Krawitt; K R Reddy; T Tominaga; D H Persing
Journal:  Ann Intern Med       Date:  1996-10-15       Impact factor: 25.391

7.  Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C.

Authors:  J M Pawlotsky; L Tsakiris; F Roudot-Thoraval; C Pellet; L Stuyver; J Duval; D Dhumeaux
Journal:  J Infect Dis       Date:  1995-06       Impact factor: 5.226

8.  Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey.

Authors:  F McOmish; P L Yap; B C Dow; E A Follett; C Seed; A J Keller; T J Cobain; T Krusius; E Kolho; R Naukkarinen
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.

Authors:  P Simmonds; E C Holmes; T A Cha; S W Chan; F McOmish; B Irvine; E Beall; P L Yap; J Kolberg; M S Urdea
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

10.  Subtype 2c of hepatitis C virus is highly prevalent in Italy and is heterogeneous in the NS5A region.

Authors:  F Maggi; M L Vatteroni; C Fornai; A Morrica; M Giorgi; M Bendinelli; M Pistello
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948
View more
  13 in total

1.  HCV genotype distribution in Flanders and Brussels (Belgium): unravelling the spread of an uncommon HCV genotype 5a cluster.

Authors:  J Verbeeck; L Kwanten; F D'Heygere; A Beguin; S Michiels; I Desombere; G Leroux-Roels; P Lemey; F Nevens; M Van Ranst
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-09-10       Impact factor: 3.267

Review 2.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

3.  Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles.

Authors:  Joep de Bruijne; Janke Schinkel; Maria Prins; Sylvie M Koekkoek; Sem J Aronson; Marijn W van Ballegooijen; Hendrik W Reesink; Richard Molenkamp; Thijs J W van de Laar
Journal:  J Clin Microbiol       Date:  2009-09-30       Impact factor: 5.948

4.  Temporal changes in HCV genotype distribution in three different high risk populations in San Francisco, California.

Authors:  Paulo Telles Dias; Judith A Hahn; Eric Delwart; Brian Edlin; Jeff Martin; Paula Lum; Jennifer Evans; Alex Kral; Steve Deeks; Michael P Busch; Kimberly Page
Journal:  BMC Infect Dis       Date:  2011-08-02       Impact factor: 3.090

Review 5.  Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.

Authors:  Lucas Wiessing; Marica Ferri; Bart Grady; Maria Kantzanou; Ida Sperle; Katelyn J Cullen; Angelos Hatzakis; Maria Prins; Peter Vickerman; Jeffrey V Lazarus; Vivian D Hope; Catharina Matheï
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

6.  Prevalence of hepatitis C virus in adult population in the Czech Republic - time for birth cohort screening.

Authors:  Roman Chlibek; Jan Smetana; Renata Sosovickova; Peter Gal; Petr Dite; Vlasta Stepanova; Lenka Pliskova; Stanislav Plisek
Journal:  PLoS One       Date:  2017-04-13       Impact factor: 3.240

7.  Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.

Authors:  Hamad Al Ashgar; Ahmed Helmy; Mohamed Q Khan; Khalid Al Kahtani; Mohammed Al Quaiz; Mohammed Rezeig; Ingvar Kagevi; Abdullah Alshehri; Abdullah Al Kalbani; Khalid Al Swat; Salim Dahab; Naser Elkum; Mohammed Al Fadda
Journal:  Ann Saudi Med       Date:  2009 Jan-Feb       Impact factor: 1.526

8.  Evaluation of a new serotyping assay for detection of anti-hepatitis C virus type-specific antibodies in serum samples.

Authors:  Elyanne Gault; Patrick Soussan; Yoann Morice; Lara Sanders; Assia Berrada; Brian Rogers; Paul Dený
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

9.  HCV genotypes, characterization of mutations conferring drug resistance to protease inhibitors, and risk factors among blood donors in São Paulo, Brazil.

Authors:  Anna S Nishiya; Cesar de Almeida-Neto; Suzete C Ferreira; Cecília S Alencar; Claudia Di-Lorenzo-Oliveira; José E Levi; Nanci A Salles; Alfredo Mendrone; Ester C Sabino
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

10.  High prevalence of hepatitis C virus type 5 in central France evidenced by a prospective study from 1996 to 2002.

Authors:  Cécile Henquell; Carole Cartau; Armand Abergel; Henri Laurichesse; Christel Regagnon; Christophe De Champs; Jean-Luc Bailly; Hélène Peigue-Lafeuille
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.